Valuation: OrthoPediatrics Corp.

Market Cap 522M 457M 422M 390M 739M 49.8B 751M 5.04B 1.98B 24.53B 1.96B 1.92B 84.42B P/E 2026 *
-17.4x
P/E 2027 * -25.4x
Enterprise Value 522M 457M 422M 390M 739M 49.8B 751M 5.04B 1.98B 24.53B 1.96B 1.92B 84.42B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.76x
Free-Float
67.15%
Yield 2026 *
-
Yield 2027 * -
1 day+0.49%
1 week+1.90%
Current month+6.27%
1 month+10.13%
3 months+27.30%
6 months+11.03%
Current year+14.47%
1 week 19.37
Extreme 19.37
21.4
1 month 17.64
Extreme 17.64
21.4
Current year 14.42
Extreme 14.42
21.4
1 year 14.42
Extreme 14.42
23.7
3 years 14.42
Extreme 14.42
45.96
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 02/06/2021
Director of Finance/CFO 58 31/01/2015
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 47 02/11/2021
Chairman 75 02/06/2021
Director/Board Member 70 31/12/2010
Date Insider Type Main position Quantity % Market Cap.
06-08Free

Director

11,436 0.0445%
06-08Free

Chief Executive Officer

119,140 0.4639%
06-08Free

Director

11,436 0.0445%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%+1.90%-9.44%-52.64% 522M
+0.82%+0.99%-16.46%+11.68% 126B
+0.84%+1.15%-1.34%-2.61% 12.9B
-1.52%+2.95%+43.33%+115.86% 8.97B
+4.14%-2.38%-47.99%-72.05% 3.98B
-0.47%-1.34%+22.30%+45.04% 2.7B
+0.61%-7.70%-14.72%-20.20% 1.74B
+0.49%-3.87%-4.88%-25.01% 1.61B
+0.47%+10.24%-62.83%-83.35% 1.49B
Average +0.65%+0.34%-10.23%-9.25% 17.81B
Weighted average by Cap. +0.74%+1.01%-12.31%+13.03%

Financials

2026 *2027 *
Net sales 265M 232M 214M 198M 375M 25.28B 381M 2.56B 1B 12.45B 995M 974M 42.86B 297M 260M 240M 221M 420M 28.28B 427M 2.86B 1.12B 13.93B 1.11B 1.09B 47.94B
Net income -26.4M -23.13M -21.33M -19.71M -37.37M -2.52B -37.99M -255M -99.94M -1.24B -99.13M -96.98M -4.27B -17.65M -15.47M -14.26M -13.18M -24.99M -1.68B -25.4M -170M -66.82M -829M -66.28M -64.84M -2.85B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
10/07/26 US$20.33 +0.49% 57,326
09/07/26 US$20.23 +2.38% 84,536
08/07/26 US$19.76 -0.30% 149,954
07/07/26 US$19.82 -3.08% 190,619
06/07/26 US$20.45 +2.51% 141,431
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
20.33USD
Average target price
24.67USD
Spread / Average Target
+21.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock